Status:

RECRUITING

Urinary Antigen Test for Stretococcus Pneumoniae Serotype Prevalence in Community Acquired Pneumonia

Lead Sponsor:

Chinese University of Hong Kong

Conditions:

Pneumonia

Eligibility:

All Genders

18+ years

Brief Summary

This is an epidemiology study for the prevalence and serotypes of pneumococcus pneumoniae in hospitalized patients with community acquired pneumonia (CAP). The serotypes of the pneumococcus pneumoniae...

Eligibility Criteria

Inclusion

  • Admitted with signs and symptoms suggestive of pneumonia which include one or more of the followings:
  • fever
  • CXR changes with consolidation, increased alveolar shadowing or hazziness
  • respiratory symptoms like increase shortness of breath, cough with sputum Raised inflammatory markers suggesting of bacterial infection with either increased white cell count or C-reactive protein, or both

Exclusion

  • Nosocomial pneumonia which is acquired \>= 48 hours after hospital admission. Pneumonia which are already known to be caused by pathogens other than pneumococcus pneumoniae.

Key Trial Info

Start Date :

December 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

1800 Patients enrolled

Trial Details

Trial ID

NCT05374018

Start Date

December 1 2021

End Date

December 31 2025

Last Update

February 12 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Medicine and Therapeutics, Prince of Wales Hospital, CUHK

Shatin, Hong Kong

Urinary Antigen Test for Stretococcus Pneumoniae Serotype Prevalence in Community Acquired Pneumonia | DecenTrialz